Getty ImagesA CDC advisory group is considering whether fully vaccinated Americans with weakened body immune systems require a booster dose of a Covid vaccine after data programs they are less likely to have antibodies to combat the illness and more likely to struggle with a so-called advancement infection.Immunosuppressed populations represent 44% of hospitalized Covid advancement cases– an infection in a fully immunized person, according to a slide presented Thursday at the companys Advisory Committee on Immunization Practices conference. The population section, that includes clients with cancer, HIV or those who have actually had organ transplants, represents only about 2.7% of the U.S. adult population, the discussion said.The Centers for Disease Control and Preventions advisory committee is also meeting to talk about the security profile of the Johnson & & Johnson vaccine.Immunocompromised people are most likely to become seriously ill from Covid and are at a higher threat of sending the infection to family and good friends, the firm said.Studies suggest that a 3rd vaccine dose may help patients whose immune systems dont respond too to a 2nd or very first dose. Four little research studies mentioned by the CDC revealed that 16% to 80% of people with weakened immune systems didnt have detectable antibodies to combat Covid after 2 shots.Among immunosuppressed clients who had no noticeable antibody reaction, 33% to 50% established an antibody action after getting an additional dose, according to the CDC.”Emerging information suggest that an extra COVID-19 vaccine dosage in immunocompromised individuals enhances antibody response and increases the percentage who respond,” according to one slide presented at the meeting.The conference comes as federal officials state booster doses of the vaccines for the general population are not needed at this time.The advisory panel can not advise additional shots for anyone till the Food and Drug Administration grants complete approval of the Covid vaccines or amends the emergency situation usage authorizations.Other nations, such as France, are currently offering 3rd shots to people dealing with cancer or other immune disabilities. The CDC group has previously said that more susceptible Americans, such as elderly people or transplant receivers, might need an additional dose.Some doctors have actually been pushing for the U.S. to allow immunosuppressed populations to get an additional dosage, according to Dr. Dan Barouch, an immunologist at Harvard Medical School who helped develop the J&J vaccine.”The hardest to immunize people are those who are immunosuppressed,” he stated, including early information reveals a third shot might be safe and efficient for those populations.Dr. Camille Kotton, a member of the CDCs advisory group, said Thursday that lots of immunosuppressed individuals are discovering additional doses of the vaccines by themselves.”I am concerned about them doing this type of in a without supervision fashion, however as it is right now, due to regulatory issues we are not enabled to advise additional dosages so patients are truly just doing what they think is finest.”– CNBCs Rich Mendez and Robert Towey contributed to this post.